3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
INDIV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Carcinoma, Non-Small-Cell Lung
72
Breast Neoplasms
63
Neoplasms
59
Leukemia, Myeloid, Acute
58
Multiple Myeloma
52
Colorectal Neoplasms
48
Lymphoma
46
Stomach Neoplasms
43
Recurrence
43
Carcinoma, Hepatocellular
43
Pancreatic Neoplasms
40
Neoplasm Metastasis
39
Melanoma
34
Prostatic Neoplasms
33
Leukemia
30
Lymphoma, Non-Hodgkin
27
Lymphoma, B-Cell
27
Lung Neoplasms
27
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Glioblastoma
24
Ovarian Neoplasms
23
Lymphoma, Large B-Cell, Diffuse
21
Esophageal Neoplasms
21
Carcinoma, Renal Cell
20
Myelodysplastic Syndromes
19
Leukemia, Lymphocytic, Chronic, B-Cell
19
Hematologic Neoplasms
19
Colonic Neoplasms
19
Head and Neck Neoplasms
18
Lymphoma, Mantle-Cell
17
Interventions
nilotinib
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Unknown
×
Retroperitoneal liposarcoma
×
Clear all
NCT02587169
2015-10-27
GEIS-27
Broto, Javier MartÃn, M.D.
Phase 1/2
Unknown
40 enrolled